Biologics Facility Design & Pharmaceutical Regulatory Aspects

  • Check with publisher
  • Published date: February 21, 2017
    • Fremont, California, United States

Overview:
This course explores some of the best practices of pharmaceutical facility design with an emphasis on regulatory aspects. FDA and other global regulatory body requirements are discussed and the reasoning behind them.

Why should you Attend:
The attendee will learn what is important in facility design from the FDA and regulatory standpoint. The attendee will understand what FDA looks for during a facility inspection. The attendee will be able to minimize possible design errors which are difficult and expensive to fix post-build. The attendee will understand what FDA looks for in reviewing the facility design and the flow patterns.

Areas Covered in the Session:
Best design practices for Pharma facilities
Best design practices for biologics facilities
Regulatory compliance for Pharma and biologics facilities design
Flow patterns and cross contamination controls

Who Will Benefit:
Compliance Manager
Facility Manager
Validation Manager
Regulatory Manager
Design Team/Architects

Speaker Profile:
John R. Godshalk currently works for the Biologics Consulting Group as a Senior Consultant. John served as a Senior Review Biochemical Engineer and Lead cGMP inspector in the Division of Manufacturing and Product Quality at CBER, FDA. He contributed to formulation of FDA policy.

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com

Result 0 votes
Compliance4All
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Monoclonal Antibody Vaccines

    Monoclonal Antibody Vaccines

    Pharmacology - Drug Development Shirley (New York) December 26, 2018 Check with publisher

    Monoclonal antibodies (mAb or moAb) are antibodies made from the same immunocytes, which are clones of a single ancestral cell. Monoclonal antibodies bind to the same epitope, so they have monovalent affinity with identical offspring of a hybridoma o...

  • GMP Vaccine Production

    GMP Vaccine Production

    Pharmacology - Drug Development Shirley (New York) December 26, 2018 Check with publisher

    For years, Creative Biolabs has consistently and effectively supported the vaccine industry with a unique range of products and related services. We provide process development and GMP manufacturing services to support your vaccine development and co...

  • VPREB3  peptide

    VPREB3 peptide

    Pharmacology - Drug Development Shirley (New York) December 21, 2018 Check with publisher

    The protein encoded by this gene is the human homolog of the mouse VpreB3 (8HS20) protein, and is specifically expressed in cell lines representative of all stages of B-cell differentiation. It is also related to VPREB1 and other members of the immun...